Chromium-51
Cr-51 · Chromium, Z = 24, A = 51
At 3.42e+15 Bq/g — 9.25e+4 Ci/g — a gigabecquerel of Cr-51 amounts to 292 ng, which is why activity rather than mass is how anyone states the quantity. Chromium-51 decays by electron capture with a half-life of 27.704 days, falling to 83.93% of today's activity in a week and 10.26% in three months.
The air kerma rate constant is small — 0.00421 mGy·m²/(GBq·h), 18× less than Cs-137 and 73× less than Co-60, ranking 76 of 96 by Γ — in the bottom quarter of the photon emitters, but above the cutoff, which 51 nuclides in this dataset are not. It takes 4.75 GBq at a metre to reach 20 µSv/h from the photons alone.
One line at 320.1 keV carries the whole of the dose rate.
Halving the air kerma rate calls for 1.72 mm of lead, or 8.30 mm of steel where lead is unwelcome, and a factor of ten calls for 5.70 mm of lead — sheet thicknesses that a glovebox or a transport container can carry. At 1 GBq and a metre it is already under 20 µSv/h with nothing in the way.
Cr-51 labelling chemistry in blood and renal clearance measurements
Cr-51 is an electron-capture radionuclide used to follow labelled red blood cells and to measure renal filtration with an edetate complex. These applications depend on different chemical preparations, rather than on a change in the isotope's radiation. The sodium chromate monograph describes production by neutron irradiation of enriched Cr-50. Following decay, the nucleus becomes V-51; most captures reach its ground state, while the less frequent excited-state route supplies the gamma signal used for measurement. Atomic relaxation also releases much softer radiation.
For red-cell work, chromate enters the cells and becomes bound to intracellular haemoglobin. The circulating label can reveal red-cell volume, loss or survival, but its disappearance is not a direct clock for the life of every cell. Chromium gradually escapes from labelled cells, and the preparation procedure can itself damage them. Consequently, an apparent survival curve combines biological removal with loss of the tracer. Once released, the chromium is largely excreted in urine and does not simply label replacement cells, an important limitation when interpreting repeated samples.
Cr-51 edetate behaves differently: the stable, water-soluble chelate remains available for glomerular filtration and binds only weakly to plasma proteins. Its renal clearance provides a measure of filtration function without relying on an endogenous marker such as creatinine. In a single-injection technique, timed plasma samples are counted against a reference aliquot representing the administered activity. The fall in plasma concentration is then analysed to estimate clearance. This avoids a timed urine collection, although the analysis still depends on appropriate sampling and a model of tracer distribution.
Distribution can be troublesome when fluid accumulates outside the circulation. The product information notes that oedema can markedly delay equilibration between plasma and interstitial fluid, making the usual single-injection approach unsuitable in that circumstance. Slower renal function also changes the useful sampling schedule. These are physiological limitations that a precise gamma count cannot resolve by itself. The same Cr-51 decay data therefore support very different interpretations: retention of a cellular label in haematology, or disappearance of a soluble filtration marker from plasma in a renal investigation.
- LNHB / DDEP, Recommended nuclear data tables: Cr-51
- USP–NF, Sodium Chromate Cr 51 Injection monograph (2017), public preview
- AnazaoHealth, Sodium Chromate 51 historical manufacturer labelling, DailyMed (not FDA-approved labelling)
- Irish Medicines Board / HPRA, Chromium [51Cr] EDTA Injection, Summary of Product Characteristics
Half-life, specific activity and dose rate
| Half-life | 27.704 days (2.394e+6 s) |
| Decay mode | electron capture |
| Specific activity | 3.42e+15 Bq/g (9.25e+4 Ci/g) |
| Air kerma rate constant Γ (δ = 20 keV) | 0.00421 mGy·m²/(GBq·h) |
| Dose rate, 1 GBq at 1 m | 0.00421 mGy/h |
| Dose rate, 1 Ci at 1 m | 0.156 mGy/h |
| Kerma-weighted mean photon energy | 320.1 keV |
A single photon line at 320 keV
3 further lines below the 20 keV cutoff, the highest at 5.44 keV and 22.8% emission probability in all, are excluded here and from Γ. Probability and dose share.
| Energy (keV) | Emission probability (%) | Share of dose rate (%) |
|---|---|---|
| 320.08 | 9.91 | 100.00 |
1.72 mm of lead halves this spectrum
Solved for the single line, narrow beam. How the half-value layer is solved.
| Material | HVL (mm) | TVL (mm) | TVL / HVL |
|---|---|---|---|
| lead | 1.72 | 5.70 | 3.32 |
| tungsten | 1.25 | 4.14 | 3.32 |
| iron | 8.30 | 27.6 | 3.32 |
| copper | 7.19 | 23.9 | 3.32 |
| concrete | 28.2 | 93.6 | 3.32 |
| water | 59.9 | 199 | 3.32 |
| aluminum | 25.3 | 84.0 | 3.32 |
With one line the ratio is the single-energy 3.32. Spectrum and attenuation ratios.
Activity over weeks and months
Ten half-lives is 277 days — for Cr-51 itself, a storage problem rather than a disposal one, since those ten half-lives already take it below 0.1% of today's activity. The mean life 1/λ is 40.0 days.
| Elapsed | Fraction remaining |
|---|---|
| 1 half-life | 50.0 % |
| 2 half-lives | 25.0 % |
| 5 half-lives | 3.13 % |
| 10 half-lives | 0.0977 % |
| Time to fall to 10 % of today's activity | 92.0 days |
| Time to fall to 1 % | 184 days |
| Time to fall to 0.1 % | 276 days |
Limits of these dose rates
- Air kerma, 1 µGy counted as 1 µSv — not H*(10).
- Model limits and internal dose.
Gamma and decay calculators for Cr-51
Computed from the IAEA Nuclear Data Section — Livechart API (ENSDF) and the NIST X-Ray Mass Attenuation Coefficients. Derivations and citations.